Beatriz Galán-Rodríguez

855 total citations
15 papers, 680 citations indexed

About

Beatriz Galán-Rodríguez is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Beatriz Galán-Rodríguez has authored 15 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cellular and Molecular Neuroscience, 6 papers in Molecular Biology and 5 papers in Neurology. Recurrent topics in Beatriz Galán-Rodríguez's work include Neurotransmitter Receptor Influence on Behavior (8 papers), Neuroscience and Neuropharmacology Research (6 papers) and Cannabis and Cannabinoid Research (4 papers). Beatriz Galán-Rodríguez is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (8 papers), Neuroscience and Neuropharmacology Research (6 papers) and Cannabis and Cannabinoid Research (4 papers). Beatriz Galán-Rodríguez collaborates with scholars based in Spain, France and Switzerland. Beatriz Galán-Rodríguez's co-authors include Emilio Fernández‐Espejo, Juan A. Flores, Peter Vanhoutte, B Antoine, Jocelyne Caboche, Fernando Rodrı́guez de Fonseca, Belén Ferrer, Rafaël Maldonado, Patricia Robledo and Jocelyne Caboche and has published in prestigious journals such as PLoS ONE, Pain and Neuroscience.

In The Last Decade

Beatriz Galán-Rodríguez

15 papers receiving 670 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beatriz Galán-Rodríguez Spain 12 386 234 226 122 106 15 680
Iria G. Dopeso‐Reyes Spain 13 338 0.9× 222 0.9× 264 1.2× 135 1.1× 99 0.9× 17 738
Silvia Buervenich Sweden 13 430 1.1× 181 0.8× 326 1.4× 97 0.8× 187 1.8× 13 987
Alexander Stumpf Germany 11 358 0.9× 266 1.1× 218 1.0× 56 0.5× 87 0.8× 18 712
Valerio Rizzo Italy 16 292 0.8× 132 0.6× 227 1.0× 67 0.5× 43 0.4× 30 634
Hussam Jourdi United States 15 424 1.1× 96 0.4× 234 1.0× 74 0.6× 66 0.6× 18 692
Franck Désarnaud France 8 292 0.8× 307 1.3× 165 0.7× 53 0.4× 31 0.3× 9 745
Annita Pintor Italy 17 688 1.8× 187 0.8× 364 1.6× 77 0.6× 190 1.8× 33 1000
Lina Emilsson Sweden 14 253 0.7× 80 0.3× 476 2.1× 213 1.7× 91 0.9× 19 981
B.‐Y. Zeng United Kingdom 12 469 1.2× 192 0.8× 150 0.7× 57 0.5× 371 3.5× 17 735
Philip A. Iredale United States 18 511 1.3× 229 1.0× 464 2.1× 95 0.8× 40 0.4× 30 1.1k

Countries citing papers authored by Beatriz Galán-Rodríguez

Since Specialization
Citations

This map shows the geographic impact of Beatriz Galán-Rodríguez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beatriz Galán-Rodríguez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beatriz Galán-Rodríguez more than expected).

Fields of papers citing papers by Beatriz Galán-Rodríguez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beatriz Galán-Rodríguez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beatriz Galán-Rodríguez. The network helps show where Beatriz Galán-Rodríguez may publish in the future.

Co-authorship network of co-authors of Beatriz Galán-Rodríguez

This figure shows the co-authorship network connecting the top 25 collaborators of Beatriz Galán-Rodríguez. A scholar is included among the top collaborators of Beatriz Galán-Rodríguez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beatriz Galán-Rodríguez. Beatriz Galán-Rodríguez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Galán-Rodríguez, Beatriz, Elodie Martin, Emmanuel Brouillet, et al.. (2016). Coupling of D2R Short but not D2R Long receptor isoform to the Rho/ROCK signaling pathway renders striatal neurons vulnerable to mutant huntingtin. European Journal of Neuroscience. 45(1). 198–206. 5 indexed citations
2.
Antoine, B, Beatriz Galán-Rodríguez, Peter Vanhoutte, & Jocelyne Caboche. (2011). Elk-1 a Transcription Factor with Multiple Facets in the Brain. Frontiers in Neuroscience. 5. 35–35. 151 indexed citations
3.
Marco, Àngel del, et al.. (2009). Morphophysiology of the Zuckerkandl's paraganglion: Effects of dexamethasone and aging. Neurobiology of Aging. 31(12). 2115–2127. 2 indexed citations
4.
Deyts, Carole, Beatriz Galán-Rodríguez, Elodie Martin, et al.. (2009). Dopamine D2 Receptor Stimulation Potentiates PolyQ-Huntingtin-Induced Mouse Striatal Neuron Dysfunctions via Rho/ROCK-II Activation. PLoS ONE. 4(12). e8287–e8287. 51 indexed citations
5.
Flores, Juan A., et al.. (2009). Fibroblast growth factor-1 within the ventral tegmental area participates in motor sensitizing effects of morphine. Neuroscience. 165(1). 198–211. 11 indexed citations
6.
Galán-Rodríguez, Beatriz, Juan Suárez, Francisco J. Bermúdez‐Silva, et al.. (2008). Oleoylethanolamide exerts partial and dose-dependent neuroprotection of substantia nigra dopamine neurons. Neuropharmacology. 56(3). 653–664. 56 indexed citations
7.
Galán-Rodríguez, Beatriz, Àngel del Marco, Juan Flores, et al.. (2007). Grafts of extra-adrenal chromaffin cells as aggregates show better survival rate and regenerative effects on parkinsonian rats than dispersed cell grafts. Neurobiology of Disease. 29(3). 529–542. 12 indexed citations
8.
Brea, José, Marián Castro, Marı́a Isabel Loza, et al.. (2006). QF2004B, a potential antipsychotic butyrophenone derivative with similar pharmacological properties to clozapine. Neuropharmacology. 51(2). 251–262. 22 indexed citations
9.
Flores, Juan A., et al.. (2005). Role for Dopamine Neurons of the Rostral Linear Nucleus and Periaqueductal Gray in the Rewarding and Sensitizing Properties of Heroin. Neuropsychopharmacology. 31(7). 1475–1488. 53 indexed citations
10.
Fernández‐Espejo, Emilio, et al.. (2005). Cells of the sympathoadrenal lineage: Biological properties as donor tissue for cell-replacement therapies for Parkinson's disease. Brain Research Reviews. 49(2). 343–354. 27 indexed citations
11.
Fernández‐Espejo, Emilio, et al.. (2005). Cannabinoid CB1 antagonists possess antiparkinsonian efficacy only in rats with very severe nigral lesion in experimental parkinsonism. Neurobiology of Disease. 18(3). 591–601. 78 indexed citations
12.
Fernández‐Espejo, Emilio, et al.. (2004). Experimental Parkinsonism Alters Anandamide Precursor Synthesis, and Functional Deficits are Improved by AM404: A Modulator of Endocannabinoid Function. Neuropsychopharmacology. 29(6). 1134–1142. 57 indexed citations
14.
Fernández‐Espejo, Emilio & Beatriz Galán-Rodríguez. (2004). Sensorimotor gating in mice is disrupted after AM404, an anandamide reuptake and degradation inhibitor. Psychopharmacology. 175(2). 220–4. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026